- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03915574
Dural Puncture Epidural Versus Epidural Anesthesia for Cesarean Delivery
Dural Puncture Epidural Versus Epidural Anesthesia for Cesarean Delivery: A Randomized, Double-blind Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to compare the onset time of anesthesia between standard epidural and Dural Puncture Epidural (DPE) for cesarean delivery. The study will hypothesize that a DPE technique with a 25-gauge spinal needle will have a faster onset and improved quality of surgical anesthesia when compared to a standard epidural. Participants will be blinded to which group they are being assigned. An unblinded anesthesiologist will insert the epidural or DPE based on randomization. After insertion of the epidural or DPE, a low dose local anesthetic infusion will be infused into the epidural catheter up until the time of surgery. This is the standard infusion used to provide pain relief in laboring women (bupivacaine 0.0625% with 2 mcg/ml fentanyl). In this way participants enrolled in the study would mimic anesthetic the conditions of a "labor epidural".
Participants will then move on to the next phase of the study. In this phase, the epidural pump will be discontinued, and anesthesia care will be conducted in the same manner as all cesarean deliveries under epidural extension anesthesia (this refers to the process of providing anesthesia using a pre-existing epidural/DPE that was inserted for the purpose of providing labor analgesia). Anesthesia will be induced in a standardized manner with 20 ml of 3% chloroprocaine. Motor and sensory block will be tested at the end of the epidural loading dose. Loss of sharp sensation will be measured using a blunt plastic neurotip® (Owen Mumford, USA) until a sensory bilateral block to the T6 dermatomal level has been reached. The T6 level measured at the xiphoid process will be marked bilaterally with a washable marker pen to guarantee the precision of the primary endpoint (which will be assumed when sensory block goes above T6). Sensory testing will be performed from caudad to cephalad (i.e. from blocked to unblocked dermatomes) to identify the first unblocked dermatome. To identify the level where the sensation of touch is first appreciated, the investigator will ask the question: "Tell me when you feel the sensation of something sharp touching your skin." Both the motor and sensory block evaluations are part of the standard clinical care of patients receiving neuraxial anesthesia. The main difference for participants enrolled in the study is that the frequency of sensory assessments will be increased so that the onset of surgical anesthesia can be accurately documented (approximately every minute and then more frequently as the sensory block approaches the primary endpoints). A second anesthesiologist, blind to the type of block will manage the clinical care of the patient from the beginning of the study (after epidural catheter placement) and will administer the induction drug (prepared by that anesthesiologist as per SOC). There will be no difference in this clinician's care of the subject than if she were not enrolled in the study. This will assess the onset of anesthesia and manage all aspects of the subject's clinical care including the documentation of the local anesthetic (LA) solution administration timing and its clinical effects. The speed of onset will be assessed from the end of epidural test dose. This will be defined as time zero and the start of anesthesia. If required, intra-operative analgesia will be offered in the form of further epidural top-up, intravenous fentanyl, ketamine, nitrous oxide or replacement of neuraxial anesthesia/conversion into general anesthesia as the standard of care (SOC).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Caesar A Guevara
- Phone Number: 501-526-5879
- Email: CAGuevara@uams.edu
Study Contact Backup
- Name: Nadir Sharawi, MD
- Phone Number: 501-319-2622
- Email: NElsharawi@uams.edu
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72204
- University of Arkansas for Medical Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Singleton pregnancy
- Gestation > 36 weeks
- ASA class II and III
- Provides written consent
- Infant of mother
- Elective or non-urgent cesarean delivery
Exclusion Criteria:
- Patient refusal
- Urgent/emergent cesarean sections
- ASA and IV or above
- Unable to understand English
- Significant back surgery or scoliosis
- Lethal fetal abnormality or likely to affect APGAR scores
- Weight > 120 kg
- Height < 150 cm
- Allergy to study solutions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dural Puncture Epidural
Participants will receive a dural puncture epidural block with a 25 gauge spinal needle followed by a standard epidural infusion (0.0625% bupivacaine + 2mcg/ml fentanyl)
|
Dural puncture created with a 25 gauge spinal needle
|
Active Comparator: Standard Epidural
Participants will have standard epidural infusion followed by a standard epidural infusion (0.0625% bupivacaine + 2mcg/ml fentanyl)
|
Control group - standard epidural (no dural puncture)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Onset Time of Surgical Anesthesia
Time Frame: 2 hours
|
The primary outcome will be the onset time of surgical anesthesia in seconds.
This will be measured from the induction of anesthesia (as defined by the beginning of injection of the "Induction 1 syringe") to the point at which sharp sensation is lost bilaterally at the T6 dermatomal level (as measured by a blunt plastic neurotip® (Owen Mumford, USA) device)
|
2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Inadequate Neuraxial Analgesia or Anesthesia
Time Frame: 2 hours
|
A composite outcome defined by failure to achieve at least a T10 bilateral sensory level pre-operatively (after 3 ml 1.5% lidocaine with 1:200,000 epinephrine 45 mg lidocaine and up to 20 ml of 0.0625% bupivacaine with 2mcg/ml fentanyl), the requirement for intraoperative analgesia supplementation, conversion to general anesthesia or repeat neuraxial procedure, or failure to achieve the primary outcome within 15 minutes between the two groups.
Analyzed as a collapsed composite (any or none)
|
2 hours
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximum Pain During Surgery (Score)
Time Frame: 2 hours
|
Maximum pain visual analogue scale during surgery (units on a scale, 0 - 10)
|
2 hours
|
Cumulative Dose of Phenylephrine Measured in Milligram Required During Surgery
Time Frame: 2 hours
|
Vasopressor requirements during surgery required to maintain systolic blood pressure within 15% of baseline
|
2 hours
|
Patient Satisfaction With Anesthetic Technique (Score)
Time Frame: 4 hours
|
Overall patient satisfaction score (units on a scale, 0 - 10)
|
4 hours
|
Neonatal Requirement for Resuscitation
Time Frame: 2 hours
|
Neonatal Apgar scores (units on a scale, 0 - 10)
|
2 hours
|
Neonatal Physiological Condition
Time Frame: 2 hours
|
Umbilical cord blood gases (pH measurement)
|
2 hours
|
Requirement for Opioids in the First 24 Hours After Surgery
Time Frame: 24 hours
|
Opioid consumption measured in milligrams.
|
24 hours
|
Anesthesia Side Effects
Time Frame: 2 hours
|
nausea, vomiting, itching (yes/no)
|
2 hours
|
Vasopressor Requirements During Surgery
Time Frame: 2 hours
|
measured in milligrams
|
2 hours
|
Bromage Score (0 - 3 Scale)
Time Frame: 3 hours
|
Motor block assessment 0 - Able to move hip, knee, and ankle
|
3 hours
|
Sensory Block Assessment
Time Frame: 3 hours
|
Assessed using sharp sensation at the midclavicular line on the abdomen and thorax Reported at the dermatomal level where sharp sensation is first felt
|
3 hours
|
Anesthesia Adverse Effects
Time Frame: 24 hours
|
Accidental dural puncture, local anesthesia systemic toxicity, high spinal, post dural puncture headache
|
24 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nadir Sharawi, MD, University of Arkansas
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 228768
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain Levels
-
University of Colorado, DenverChildren's Hospital ColoradoWithdrawnLevels of PainUnited States
-
University Health Network, TorontoQueen's UniversityNot yet recruitingAntithrombin III Levels | Albumin LevelsCanada
-
Cukurova UniversityRecruitingLabor Pain, Labor Perception, Hormone Levels and Childbirth ComfortTurkey
-
National Cancer Institute (NCI)CompletedHPV16 Anitbody Levels Post Vaccination | HPV18 Antibody Levels Post VaccinationUganda
-
KGK Science Inc.Healthy Directions, LLCCompletedCoQ10 Blood Levels | CoQ10 Blood Levels With Statin UseCanada
-
Democritus University of ThraceActive, not recruitingCholesterol LevelsGreece
-
Parkland Health and Hospital SystemCompletedStress LevelsUnited States
-
Bucci Laser Vision InstituteCompletedCardioprotective LevelsUnited States
-
University of British ColumbiaUniversity of British Columbia School of Population and Public HealthCompleted
-
Children's Hospital of PhiladelphiaChildren's Anesthesiology Associates, Ltd.Completed
Clinical Trials on 25G Dural Puncture Epidural
-
Cairo UniversityCompletedGynecologic Disease Requiring Vaginal Operation Under Neuraxial AnesthesiaEgypt
-
University of ChileCompletedEpidural Analgesia | Labor PainChile
-
Medical University of South CarolinaCompletedLabor Pain | Labor AnalgesiaUnited States
-
Cairo UniversityCompletedGynecologic Diseases Requiring Vaginal HysterectomyEgypt
-
Reham Ali Abdelhaleem AbdelrahmanCompleted
-
National Research Centre, EgyptCairo UniversityWithdrawnDural Puncture Epidural Technique
-
Cairo UniversityActive, not recruitingDural Puncture Epidural TechniqueEgypt
-
Cairo UniversityCompletedGynecologic Disease Requiring Laparoscopic Hysterectomy Under Neuraxial AnesthesiaEgypt
-
Mayo ClinicUniversity of British ColumbiaEnrolling by invitationAnalgesia | AnesthesiaUnited States, Canada
-
Zongxun LinRecruiting